(Q33890720)

29 July 2017

1 reference

title

Evidence-based medicine in the treatment of non-small-cell lung cancer (English)

1 reference

29 July 2017

main subject

evidence-based medicine

1 reference

1 reference

Reif MS

1

1 reference

29 July 2017

Socinski MA

series ordinal

2

1 reference

29 July 2017

Rivera MP

series ordinal

3

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Clinics in Chest Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

107-20, ix

1 reference

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Treatment of stage II lung cancer (T1N1 and T2N1).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

The role of surgery in N2 lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Survival after resection of stage II non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Neoadjuvant chemotherapy of stage III‐A and B lung carcinoma using the pacco regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970011-3

7 January 2021

10.1016/S0272-5231(05)70011-3

Identifiers

DOI

1 reference

29 July 2017

1 reference